Tsc1 is a Critical Regulator of Macrophage Survival and Function

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1406-1418

  Fang, Chunmin ^a   Yu, Juan ^b   Luo, Yuechen ^a   Chen, Song ^b   Wang, Weiqiang ^a   Zhao, Chunxiao ^a   Sun, Zhina ^a   Wu, Wantong ^a   Guo, Wei ^a   Han, Zhongchao ^a   Hu, Xiao ^a   Liao, Fang ^b   Feng, Xiaoming ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Macrophage; mTOR; Tsc1

Indexed keywords

ARGINASE; CARBON TETRACHLORIDE; CD209A PROTEIN; CD209C PROTEIN; CD209D PROTEIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CRE RECOMBINASE; CXCL9 CHEMOKINE; FIZZ1 PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYSOZYME; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN; RANTES; REACTIVE OXYGEN METABOLITE; TUBEROUS SCLEROSIS COMPLEX 1; UNCLASSIFIED DRUG; CHEMOKINE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PHAGOCYTOSIS; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM EXUDATE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PHAGOCYTOSIS;

MAMMALIA; MUS;

ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; MYELOID CELLS; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84936980783     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430306     Document Type: Article

References (34)

1. Orlova KA, Crino PB: The tuberous sclerosis complex. Ann N Y Acad Sci 2012;1184:87-105.
2. Harkewicz R, Hartvigsen K, Almazan F: Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein. J Biol Chem 2008;283:10241-10251.
3. Weichhart T, Seamann MD: The multiple facts of mTORin immunity. Trends immunol 2009;30:218-226.
4. WangY, Huang G, Zeng H, Yang K, Lamb RF, Chi H: Tuberous Sclerosis l(Tscl)-dependent metabolic checkpoint controls development of dendritic cells. Proc Natl Acad Sci USA 2013;110:E4894-E4903.
5. Xie DL, Wu J, Lou YL, Zhong XP: Tumor suppressor Tscl is critical for T-cell anergy. Proc Natl Acad SciUSA 2012;109:14152-14157.
6. Gallis SJ, Borregaard N, Wynn TA: Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011;12:1035-1044.
7. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subset. Nat Rev Immunol 2011;11:723-737.
8. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969.
9. SicaA, Mantovani A: Macrophage plasticity and polarization: in vivo Veritas. J Clin Invest 2012;122:787-795.
10. Mills CD, Ley K: Ml and M2 macrophages: The chicken and the egg of immunity. J Innate Immun 2014;6:716-726.
11. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity 2010;32:593-604.
12. Kurihara T, Warr G, Loy J, Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J EXP Med 1997;186:1757-1762.
13. Boring L, Gosling J, Chensue SW: Impaired monocyte migration and reduced type 1 (TH1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561.
14. Lin H, Chang KT, Hung CC, Kuo CH, Hwang SJ, Chen HC, Hung CH, Lin SF: Effects ofthe mTOR inhibitor Rapamycin on monocyte-secreted chemokines. BMC immunol 2014;15:37.
15. Babior BM, Kipnes RS, Curnutte JT: The Productions by leukocytes of superoxide: A potential bactericidal agent. J Clin Invest 1973;52:741-744.
16. Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T: The TSC-mTOR pathway regulates macrophages polarization. Nat Commun 2013;4:2834.
17. Zhu L, Yang T, Li L, Hou Y, Hu X, Zhang L, Tian H, Zhao Q, Peng J, Zhang H, Wang R Yang Z, Zhang L, Zhao Y: Tscl controls macrophages polarization to prevent inflammatory disease. Nat Commun 2014;5:4694.
18. Wang Y, Huang G, Vogel P, Neale G, Reizis B, Chi H: Transforming growthfactor beta-activated kinae (TAK1] dependent checkpoint in the survival of dendritic cells promotes immune homestasis and function. Proc Natl Acad Sci USA 2012;109:E343-352.
19. Xiaoyu Hu, Yushan Zhou, Kui Dong: Programming of the Development of Tumor-Promoting Neutrophils by Mesenchymal Stromal Cells. Cell Physiol Biochem 2014;33:1802-1814.
20. EI Kasmi KC, Quails JE, Pesce JT: Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat immunol 2008;9:1399-1406.
21. Van den Bossche J, Lemers WH, Koehler ES: Pivotal Advance:Arginase-l-independent polyamine production stimulates the expression ofIL-4-induced alternativelyactivated macrophage markers while inhibiting LPS-induced expression of inflammatory genes. J Leukoc Biol 2012; 91:685-699.
22. Martinez FO, Helming L, Gordon S: Alternatice activation of macrophages:an immunologic functional perspective. Annu Rev Immunlo 2009;27:451-483.
23. Martinez FO, Gordon S, Locati M, Mantovani A: Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patters of gene expression. J Immunol 2006;177:7303-7311.
24. Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI: Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010;39:171-183.
25. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clinl Invest 2007;117:175-184.
26. Biswas SK, Sica A, Lewis CE: Plasticity of macrophages function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008;180:2011-2017.
27. Charo IF, Peters W: Chemokine receptor2(CCR2) in atherosclerosis, infections diseases, and regulation of T-cell polarization. Microcirculation 2003;10:259-264.
28. Ness TL, Kunkel SL, Hogaboam GM: CCR5 antagonists: The answerto inflammatory disease? Expert Opin Ther Pat 2006;16:1051-1065.
29. Bajetto A, Bonavia R, Barber S. Florio T: Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001;22:147-184.
30. Ai D, Jiang H, Westerterp M: Disruption of Mammalian target of Rapamycin complex 1 in macrophages decreased chemokine gene expression and atherosclerosis. Circ Res 2014;114:1576-1584.
31. Perino A, Pols TW, Nomura M: TGR5 reduces macrophage migration through mTOR-induced C/EBPp differential translation. J Clin Invest 2014;doi:10:1172/JCI76289.
32. Wynn TA, Chawla A, Pollard JW: Macrophage biology in development, homeostasis and disease. Nature 2013;496:445-455.
33. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-737.
34. Gordon S: The macrophage: past, presentand future. EurJ Immunol 2007;37:9-17.